|
General Population |
CCS All Malignancies |
CCS All Malignancies |
CCS
All Malignancies |
CCS Hematological Malignancies |
CCS Hematological
Malignancies |
CCS Hematological Malignancies |
|
% w/o protection |
% w/o protection |
95% CI |
P value |
% w/o
protection |
95% CI |
P value |
Measles |
5% |
23% |
11-42% |
P=0.0002 |
30% |
14-51.8% |
P<0.0001 |
Mumps |
26% |
33% |
16-56% |
P=0.16 |
41.6% |
19-68% |
P=0.064 |
Rubella |
1% |
23.8% |
10-45% |
P<0.0001 |
25% |
10-49% |
P<0.0001 |
VZV |
1% |
56.5% |
36.8-74% |
P<0.0001 |
68.75% |
44-85.8% |
P<0.0001 |
Tetanus |
14.2% |
50% |
29.9-70% |
P<0.0001 |
60% |
35.7-80% |
P<0.0001 |
Hepatitis B |
33% |
66% |
43.7-83.7% |
P=0.0007 |
76.9% |
49.7-91.8% |
P=0.00019 |